A novel sirolimus drug eluting stent for Small-Vessel Disease: results from en-ABL e-registry

Autores: L Testa, S Dani, D Desai, R Pandya, P Parekh, A Vasavada, N Bhalani, C Sheth, A Sharma, D Shah - 2019

Merging the properties of a sirolimus coated balloon with those of a bioresorbable polymer sirolimus eluting stent to address the “diabetes issue” Results from the En-Abl multicenter registry

Autores: Testa L, Dani S, Desai D, Pandya R, Parekh P, Bhalani N, Sharma A, Seth C, Doshi M, Sojitra P, Chodvadiya P, Dutta G, Bedogni F. - 2018

Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres

Autores: Enrico Fabris, Gianluca Caiazzo, Ismail Dogu Kilic, Roberta Serdoz, Gioel Gabrio Secco, Gianfranco Sinagra, Renick Lee, Nicolas Foin, Carlo Di Mario - 2016

Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon

Autores: Gioel Gabrio Secco, Matteo Ghione, Alessio Mattesini, Gianni Dall'Ara, Liviu Ghilencea, Kadriye Kilickesmez, Giuseppe De Luca, Rossella Fattori, Rosario Parisi, Paolo Nicola Marino, Alessandro Lupi, Nicolas Foin, Carlo Di Mario - 2016

A novel approach to treat in-stent restenosis: 6- and 12-month results using the everolimus-eluting bioresorbable vascular scaffold

Autores: Peiman Jamshidi, MD; Tobias Nyffenegger, MD; Zaid Sabti, MD; Elefteri Buset, MD; Stefan Toggweiler, MD; Richard Kobza, MD; Florim Cuculi, MD. - 2016

Coronary In-stent restenosis: Where are we Now?

Autores: Moscarella E, Ielasi A, Cortese B, Varricchio A. - 2016